629 related articles for article (PubMed ID: 33556642)
1. GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease.
Zheng J; Xie Y; Ren L; Qi L; Wu L; Pan X; Zhou J; Chen Z; Liu L
Mol Metab; 2021 May; 47():101180. PubMed ID: 33556642
[TBL] [Abstract][Full Text] [Related]
2. GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer's disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway.
Xie Y; Zheng J; Li S; Li H; Zhou Y; Zheng W; Zhang M; Liu L; Chen Z
Biochem Pharmacol; 2021 Jun; 188():114578. PubMed ID: 33895160
[TBL] [Abstract][Full Text] [Related]
3. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
Park JS; Kam TI; Lee S; Park H; Oh Y; Kwon SH; Song JJ; Kim D; Kim H; Jhaldiyal A; Na DH; Lee KC; Park EJ; Pomper MG; Pletnikova O; Troncoso JC; Ko HS; Dawson VL; Dawson TM; Lee S
Acta Neuropathol Commun; 2021 Apr; 9(1):78. PubMed ID: 33902708
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide Protects Against Brain Amyloid-β
Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
[TBL] [Abstract][Full Text] [Related]
6. APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis.
Farmer BC; Williams HC; Devanney NA; Piron MA; Nation GK; Carter DJ; Walsh AE; Khanal R; Young LEA; Kluemper JC; Hernandez G; Allenger EJ; Mooney R; Golden LR; Smith CT; Brandon JA; Gupta VA; Kern PA; Gentry MS; Morganti JM; Sun RC; Johnson LA
Mol Neurodegener; 2021 Sep; 16(1):62. PubMed ID: 34488832
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.
Allaman I; Gavillet M; Bélanger M; Laroche T; Viertl D; Lashuel HA; Magistretti PJ
J Neurosci; 2010 Mar; 30(9):3326-38. PubMed ID: 20203192
[TBL] [Abstract][Full Text] [Related]
8. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte remodeling in the beneficial effects of long-term voluntary exercise in Alzheimer's disease.
Belaya I; Ivanova M; Sorvari A; Ilicic M; Loppi S; Koivisto H; Varricchio A; Tikkanen H; Walker FR; Atalay M; Malm T; Grubman A; Tanila H; Kanninen KM
J Neuroinflammation; 2020 Sep; 17(1):271. PubMed ID: 32933545
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
Salles GN; Calió ML; Hölscher C; Pacheco-Soares C; Porcionatto M; Lobo AO
Neuropharmacology; 2020 Jan; 162():107813. PubMed ID: 31628935
[TBL] [Abstract][Full Text] [Related]
11. Role of astrocytic glycolytic metabolism in Alzheimer's disease pathogenesis.
Fu W; Jhamandas JH
Biogerontology; 2014 Dec; 15(6):579-86. PubMed ID: 25106114
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathway.
Yi J; Chen B; Yao X; Lei Y; Ou F; Huang F
J Cell Biochem; 2019 Oct; 120(10):18053-18065. PubMed ID: 31190362
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Function of High Glycolytic Activity in Astrocytes: Common Roles in Stroke and Neurodegenerative Diseases.
Takahashi S
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207355
[TBL] [Abstract][Full Text] [Related]
15. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
Beggiato S; Cassano T; Ferraro L; Tomasini MC
Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis links alterations of bioenergetics, mitochondria-ER interactions and proteostasis in hippocampal astrocytes from 3xTg-AD mice.
Dematteis G; Vydmantaitė G; Ruffinatti FA; Chahin M; Farruggio S; Barberis E; Ferrari E; Marengo E; Distasi C; Morkūnienė R; Genazzani AA; Grilli M; Grossini E; Corazzari M; Manfredi M; Lim D; Jekabsone A; Tapella L
Cell Death Dis; 2020 Aug; 11(8):645. PubMed ID: 32811809
[TBL] [Abstract][Full Text] [Related]
17. An inverse-Warburg effect and the origin of Alzheimer's disease.
Demetrius LA; Simon DK
Biogerontology; 2012 Dec; 13(6):583-94. PubMed ID: 23086530
[TBL] [Abstract][Full Text] [Related]
18. Elevated CLOCK and BMAL1 Contribute to the Impairment of Aerobic Glycolysis from Astrocytes in Alzheimer's Disease.
Yoo ID; Park MW; Cha HW; Yoon S; Boonpraman N; Yi SS; Moon JS
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114015
[TBL] [Abstract][Full Text] [Related]
19. Aerobic glycolysis during brain activation: adrenergic regulation and influence of norepinephrine on astrocytic metabolism.
Dienel GA; Cruz NF
J Neurochem; 2016 Jul; 138(1):14-52. PubMed ID: 27166428
[TBL] [Abstract][Full Text] [Related]
20. Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity.
Fu W; Shi D; Westaway D; Jhamandas JH
J Biol Chem; 2015 May; 290(20):12504-13. PubMed ID: 25814669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
